title: Accelerated denaturation of hemoglobin and the antimalarial action of chloroquine.
abstract: To study the antimalarial action of chloroquine, normal mouse erythrocytes were used as surrogates for erythrocytoid bodies. These bodies form in the endosomes of intraerythrocytic malaria parasites as they feed on their host and consist of erythrocyte cytoplasm enclosed in a vestige of the erythrocyte membrane. In suspensions of normal erythrocytes or lysates (equivalent to 5 microl of erythrocytes per ml in each case), hemoglobin underwent denaturation when it was incubated at 38 degrees C in 150 mM sodium acetate (pH 5). It is reasonable to assume that the same phenomenon occurs in acidic endosomes. Addition of 100 microM chloroquine to the incubation mixture caused the rate of hemoglobin denaturation to double to 40 nanomoles per hour per ml of packed erythrocytes. This effect required the presence of erythrocyte stroma and was inhibited by reducing the temperature to 24 degrees C or increasing the pH to 6. We propose that the primary antimalarial action of chloroquine is to bind to ferriprotoporphyrin IX (FP) and remove it from oxidized hemoglobin, thus producing toxic FP-chloroquine complexes and an excess of denatured globin. Furthermore, we suggest that these substances inhibit endosomal maturation and thereby cause hemoglobin accumulation in immature endosomes and masking of the lipids needed for FP dimerization. The term "masking" is used to signify that unsaturated lipids are present in parasitized erythrocytes but are specifically unavailable to promote FP dimerization.
authors.affiliation: Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO 63104, USA. coy.fitch@va.gov
authors.forename: Coy D
authors.initials: CD
authors.lastname: Fitch
authors.forename: Natrice V
authors.initials: NV
authors.lastname: Russell
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use; D002738:Chloroquine / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use; D004912:Erythrocytes / Q000737:chemistry*; D006427:Hemin / Q000378:metabolism*; D006454:Hemoglobins / Q000378:metabolism*; D006461:Hemolysis; D006863:Hydrogen-Ion Concentration; D008297:Male; D051379:Mice; D011489:Protein Denaturation; D013696:Temperature
chemical_list: D000962:Antimalarials; D006454:Hemoglobins; D006427:Hemin; D002738:Chloroquine